ConductScience.org, home

Paper7013003

Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.

Bergeron MG and 3 others. Rev Infect Dis, 1981. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo. Papers, record 7013003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7013003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.
PubMed
Journal
Rev Infect Dis
PubMed
Year
1981
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.5
iCite
Revised in PubMed
2019-08-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bergeron MGM G
2Beauchamp DD
3Poirier AA
4Bastille AA

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GentamicinsMajor topic
Penicillin GMajor topic
Animals
Dose-Response Relationship, Drug
Escherichia coli Infections
Female
Models, Biological
Pyelonephritis
Rabbits
Rats
Streptococcal Infections
Thrombosis
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
11095811Pharmacologic Basis for the Treatment of Pyelonephritis.Curr Infect Dis Rep1999https://conductscience.org/library/papers/11095811PubMed
9021198Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9021198PubMed
7114835Effect of method of administration on extravascular penetration of four antibiotics.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7114835PubMed
6723636Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6723636PubMed
6098475Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6098475PubMed
3878128Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3878128PubMed
3545070Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3545070PubMed
3439803Gentamicin dosing strategies for dogs with subclinical renal dysfunction.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3439803PubMed
3300530Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300530PubMed
3145857Mouse model for evaluation of antibiotic treatment of acute and chronic infections.Eur J Clin Microbiol Infect Dis1988https://conductscience.org/library/papers/3145857PubMed
3105445Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3105445PubMed
1952849Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1952849PubMed
1444302Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1444302PubMed
1416826Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1416826PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7013003

GET https://conductscience.org/api/papers/v1/7013003/authors